Systematic Review of Controlled Clinical Trials on the Use of Ursodeoxycholic Acid for the Prevention of Hepatic Veno-occlusive Disease in Hematopoietic Stem Cell Transplantation
Open Access
- 1 February 2007
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 13 (2) , 206-217
- https://doi.org/10.1016/j.bbmt.2006.09.012
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Hepatic veno-occlusive disease (VOD) with complete occlusion of liver venules after tandem autologous stem cell transplantation - successful treatment with high-dose methylprednisolone and defibrotideZeitschrift für Krebsforschung und Klinische Onkologie, 2002
- A randomized trial of heparin plus ursodiol vs heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantationBone Marrow Transplantation, 2002
- The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantationAmerican Journal of Hematology, 2000
- Defibrotide as salvage therapy for refractory veno-occlusive disease of the liver complicating allogeneic bone marrow transplantationBone Marrow Transplantation, 1999
- Parenteral glutamine protects hepatic function during bone marrow transplantationBone Marrow Transplantation, 1998
- Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institutionBone Marrow Transplantation, 1997
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive diseaseAnnals of Hematology, 1993
- DefibrotideDrugs, 1993
- Immunomodulatory Effects of Ursodeoxycholic Acid on Immune ResponsesHepatology, 1992